Treatment of blepharospasm with high dose brow injection of botulinum toxin. 1987

R W Kristan, and O G Stasior
Department of Ophthalmology, Monmouth Medical Center, Long Branch, New Jersey.

We treated 12 patients who had essential blepharospasm with brow and eyelid injections of botulinum toxin. The eyelid injections were kept constant while varying doses were used in the brow. The duration of the effect of the toxin was longer and the degree of improvement greater in those patients receiving more than 20 U in the brow than in those receiving less than 20 U. However, the degree of improvement in spasm intensity in those patients receiving greater than 20 U was similar. Ptosis occurred in seven patients. No systemic side effects were noted.

UI MeSH Term Description Entries
D007279 Injections, Subcutaneous Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin. Subcutaneous Injections,Injection, Subcutaneous,Subcutaneous Injection
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D001764 Blepharospasm Excessive winking; tonic or clonic spasm of the orbicularis oculi muscle. Blepharospasms
D001905 Botulinum Toxins Toxic proteins produced from the species CLOSTRIDIUM BOTULINUM. The toxins are synthesized as a single peptide chain which is processed into a mature protein consisting of a heavy chain and light chain joined via a disulfide bond. The botulinum toxin light chain is a zinc-dependent protease which is released from the heavy chain upon ENDOCYTOSIS into PRESYNAPTIC NERVE ENDINGS. Once inside the cell the botulinum toxin light chain cleaves specific SNARE proteins which are essential for secretion of ACETYLCHOLINE by SYNAPTIC VESICLES. This inhibition of acetylcholine release results in muscular PARALYSIS. Botulin,Botulinum Neurotoxin,Botulinum Neurotoxins,Clostridium botulinum Toxins,Botulinum Toxin,Neurotoxin, Botulinum,Neurotoxins, Botulinum,Toxin, Botulinum,Toxins, Botulinum,Toxins, Clostridium botulinum
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

R W Kristan, and O G Stasior
January 1996, Revista do Hospital das Clinicas,
R W Kristan, and O G Stasior
January 1987, L'Annee therapeutique et clinique en ophtalmologie,
R W Kristan, and O G Stasior
February 1985, American journal of ophthalmology,
R W Kristan, and O G Stasior
January 1990, Medicina,
R W Kristan, and O G Stasior
September 1989, Mayo Clinic proceedings,
R W Kristan, and O G Stasior
March 1985, Archives of ophthalmology (Chicago, Ill. : 1960),
R W Kristan, and O G Stasior
January 2021, Nepalese journal of ophthalmology : a biannual peer-reviewed academic journal of the Nepal Ophthalmic Society : NEPJOPH,
R W Kristan, and O G Stasior
January 1991, Archivos de neurobiologia,
R W Kristan, and O G Stasior
January 1991, Archivos de neurobiologia,
R W Kristan, and O G Stasior
January 1988, Advances in neurology,
Copied contents to your clipboard!